See also this year's filing and all EDGAR filings for this company.
PDF Report 0001253689_2020_Crescent_Biopharma_INC.pdf
Logs
| warning | The stock_price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001253689, Crescent Biopharma INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 162,527,763 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 822,920 |
| 3 | remainder_Assets | 4,618,996 |
| 4 | LiabilitiesCurrent | 10,950,576 |
| 5 | LiabilitiesNoncurrent | 2,818,516 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 15,827,600 |
| 9 | ResearchAndDevelopmentExpense | 50,391,830 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 3,615,753 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 167,969,679 |
| 1 | Liabilities | 13,769,092 |
| 2 | Expenses | 66,219,430 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 154,200,587 |
| 5 | NetIncome | -62,603,677 |
| 6 | ComprehensiveNetIncome | -62,603,677 |
| 7 | BaseVar | 125,786,977 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.01 |
| 9 | EconomicCapitalRatio | 3.69 |